ACORN

Clarient, ACORN collaborate to improve cancer treatment

Wednesday, December 14, 2011 12:22 PM

Clarient, a GE Healthcare company, and ACORN Research have formed a strategic collaboration around molecular testing of tumor samples. The agreement will establish a standardized testing protocol across the ACORN network of oncology community practices and hospitals with treatment guidelines and clinical trial opportunities. These processes have the potential to improve oncology treatment and research that aim to deliver targeted treatments based on the specific genetic markers for each patient.

More... »

ACORN Research collaborates with AdeptBio

Friday, November 11, 2011 11:23 AM

ACORN Research has expanded its research footprint to support advances in personalized medicine and translational research, by offering high-quality biospecimens coupled with premium data to industry and academic research through its partnership with AdeptBio.

More... »

ACORN reports positive research results

Friday, July 1, 2011 10:17 AM

Accelerated Community Oncology Research Network (ACORN) reported positive results of a large, double-blind, randomized phase IIb trial in patients with breast cancer. The study evaluated a drug regimen for the treatment of locally advanced or metastatic breast cancer. The regimen, NexavarR (sorafenib) tablets in combination with either Gemcitabine (GemzarR) or Capecitabine (XelodaR), found statistically significant improvement in progression-free survival.  Forty investigative sites enrolled 160 patients over a three-year period.

More... »

WCCT Names Vice President of Clinical Operations

Wednesday, September 24, 2008 04:29 PM

West Coast Clinical Trials (WCCT) appointed J. Jon Rojas vice president, clinical operations, for the Cypress, Calif.-based early stage CRO. Rojas will provide management oversight and strategic direction of the phase I business unit. Prior to joining WCCT, Rojas served as senior vice president of clinical services and support at OmniComm.

More... »